Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Actuate Therapeutics, Inc. (ACTU) had Return on Tangible Equity of -26189.04% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-27.29M |
|
-- |
|
-- |
|
$25.16M |
|
$-25.16M |
|
$-2.12M |
|
$-27.29M |
|
$-27.29M |
|
$-27.29M |
|
$-27.29M |
|
$-27.29M |
|
$-27.29M |
|
$-25.16M |
|
$-25.16M |
|
8.37M |
|
8.37M |
|
$-3.26 |
|
$-3.26 |
|
| Balance Sheet Financials | |
$9.21M |
|
-- |
|
$0.11M |
|
$9.32M |
|
$8.80M |
|
-- |
|
$0.41M |
|
$9.21M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
19.53M |
|
| Cash Flow Statement Financials | |
$-21.84M |
|
-- |
|
$27.53M |
|
$2.96M |
|
$8.64M |
|
$5.68M |
|
$2.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26192.63% |
|
|
Return on Tangible Equity |
-26189.04% |
-292.81% |
|
-26189.05% |
|
$0.01 |
|
$-2.61 |
|
$-2.61 |
|